Related Experiment Video
Updated: Sep 12, 2025
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Targeting tumor stroma via ultrasound-activated nanodroplets: Disrupting exosome-driven microenvironment crosstalk
Yuanyuan Yang1, Rui Liu1, Hongtao Lv2
1Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
Abstract:
The tumor microenvironment (TME) plays a crucial role in the initiation and progression of tumors. Therefore, targeting the TME has emerged as an important strategy in antitumor therapy. Two critical stromal cell types in the TME-tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs)-secrete exosomes that promote tumor growth, invasion, metastasis, drug resistance, and immune evasion. Inhibiting the secretion of exosomes by these cells may represent an effective strategy for antitumor therapy targeting the TME. In this study, we constructed Man/HTTIPKV-imipramine-nanodroplets (M/H-I-NDs) with a size of 258.93 nm, which were surface-modified with two specific ligands (Man and HTTIPKV) and loaded with the exosome inhibitor imipramine, using an ultrasonic emulsification and oscillation method. We systematically evaluated the characteristics, properties, biosafety, ultrasound imaging capability, and targeting efficiency of M/H-I-NDs. We validated the ability of M/H-I-NDs combined with ultrasound-targeted microbubble destruction (UTMD) to inhibit exosomes derived from TAMs and CAFs. We investigated the in vitro and in vivo antitumor and antimetastatic effects of M/H-I-NDs combined with UTMD using murine 4 T1 breast cancer cells and tumor models. M/H-I-NDs exhibited excellent targeting ability, drug delivery, and penetration efficiency and favorable biosafety. M/H-I-NDs showed 3.4-fold higher accumulation in mice tumor tissue than in non-targeted NDs. The study showed that the drug release of M/H-I-NDs combined with UTMD is about 50 % higher than that of non-stimulated M/H-I-NDs within 64 h. The M/H-I-NDs and UTMD combination significantly inhibited the generation of exosomes by 87.5 % derived from TAMs and 54 % derived from CAFs. The activity of tumor cells in vitro decreased by about 80 %, and the tumor volume in mice in vivo decreased by about 85 % (Day 14), demonstrating strong antitumor effects in vitro and in vivo. The combined application of M/H-I-NDs and UTMD, as a stroma-targeted therapeutic strategy integrating dual-ligand precision and ultrasound-enhanced drug delivery to simultaneously disrupt TAMs and CAFs exosome signaling, may represent a potential clinical antitumor treatment.
Insights
This study developed novel nanodroplets (M/H-I-NDs) that target tumor microenvironment cells, inhibiting exosome release and demonstrating significant antitumor and antimetastatic effects in preclinical models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- The tumor microenvironment (TME) is critical for tumor progression.
- Tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) in the TME secrete exosomes that promote tumor growth and metastasis.
- Targeting TME stromal cells and their exosome secretion is a promising antitumor strategy.
Purpose of the Study:
- To construct and evaluate Man/HTTIPKV-imipramine-nanodroplets (M/H-I-NDs) for targeting TAMs and CAFs.
- To investigate the combined therapeutic effect of M/H-I-NDs with ultrasound-targeted microbubble destruction (UTMD) against breast cancer.
- To assess the in vitro and in vivo antitumor and antimetastatic efficacy of this combined therapy.
Main Methods:
- M/H-I-NDs were synthesized using ultrasonic emulsification and loaded with imipramine, a novel exosome inhibitor.
- Surface modification with Man and HTTIPKV ligands enhanced targeting efficiency.
- In vitro and in vivo studies utilized 4T1 breast cancer cells and murine models, combined with UTMD for drug delivery.
Main Results:
- M/H-I-NDs demonstrated high tumor tissue accumulation (3.4-fold increase) and efficient drug penetration.
- The M/H-I-NDs/UTMD combination significantly inhibited exosome generation from TAMs (87.5%) and CAFs (54%).
- This therapy resulted in substantial in vitro tumor cell activity reduction (~80%) and in vivo tumor volume decrease (~85%).
Conclusions:
- M/H-I-NDs combined with UTMD represent an effective stroma-targeted therapy for breast cancer.
- This strategy simultaneously disrupts TAM and CAF exosome signaling via dual-ligand targeting and ultrasound enhancement.
- The approach shows significant potential for clinical translation in antitumor treatment.
More Related Videos
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
08:28Synthesis of Phase-shift Nanoemulsions with Narrow Size Distributions for Acoustic Droplet Vaporization and Bubble-enhanced Ultrasound-mediated Ablation
Published on: September 13, 2012
